Carson Wealth (CWM LLC)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-182
Closed -$23K 289
2013
Q4
$23K Buy
+182
New +$11.8K ﹤0.01% 355

Other funds holding GSK

Carson Wealth (CWM LLC)'s GSK Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its GSK (GSK) stake by 1% in Q1 2026, selling an estimated $85.2K and leaving 154,094 shares worth $8.5M. The position accounts for 0.02% of the portfolio, ranked #609.

Carson Wealth (CWM LLC) first reported a position in GSK in Q3 2013 and has held it in 44 quarters since. The position peaked at $9.31M in Q2 2022. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Carson Wealth (CWM LLC) held 154,094 shares of GSK worth $8.5M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 1,572 GSK shares in Q1 2026, an estimated $85.2K.
  • GSK made up 0.02% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #609 holding.
  • Carson Wealth (CWM LLC) first reported a position in GSK in Q3 2013 and has held it in 44 quarters since.
  • Carson Wealth (CWM LLC)'s GSK position peaked at $9.31M in Q2 2022.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.